Barclays Maintains Equal-Weight on CME Group, Raises Price Target to $281
Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and raises the price target from $270 to $281.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and raises the price target from $270 to $281.
Marex Group Limited announced that Chair Robert Pickering has stepped down after a three-year tenure that oversaw the company's transformation from a private firm to a NASDAQ-listed business with over $5 billion market capitalization. John Pietrowicz, former CFO of CME Group, has been appointed as the new Chair. The leadership transition comes as Marex continues its growth trajectory following its successful IPO in April 2024.
Treasury Auction Will Be The Test Please click here for an enlarged chart of SPDR S&P 500 ETF Trust (NYSE:SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the
Alphabet's Google Cloud division has accumulated a $514 billion backlog and is accelerating revenue growth at 82%, supported by massive $811 billion capital expenditure commitments. While search remains a high-margin cash cow generating $63 billion quarterly revenue, Google Cloud could surpass it as the primary growth engine by next year. Despite near-term free cash flow pressures, analysts project the cloud segment will drive the majority of Alphabet's projected $300 billion free cash flow by 2031, making the stock's current 17x P/E valuation potentially attractive for patient investors.
The article compares ASML and Broadcom as investment options for 2026. ASML dominates lithography equipment with a 29.4% net margin and low debt, while Broadcom leads in AI infrastructure with a 36.2% net margin and exceptional 23.9% revenue growth. Despite ASML's monopoly position, Broadcom emerges as the better buy due to faster growth (28% average vs. 17%), higher profitability (48.6% operating margin vs. 35.4%), and more attractive forward valuation, though both stocks are well-positioned for technological trends.
The article argues that the market has incorrectly priced Alphabet/Google as a loser in the AI race, despite evidence suggesting the company is performing better than its stock valuation reflects. The author contends that what is happening operationally at Google tells a different story than what the market pricing indicates.